Epidermal growth factor receptor and variant III targeted immunotherapy. - Wikidata - wikimedia - TriplyDB

Epidermal growth factor receptor and variant III targeted immunotherapy.

Epidermal growth factor receptor and variant III targeted immunotherapy.

http://www.wikidata.org/entity/Q34391942

about

Are BiTEs the "missing link" in cancer therapy?New anti-cancer chemicals Ertredin and its derivatives, regulate oxidative phosphorylation and glycolysis and suppress sphere formation in vitro and tumor growth in EGFRvIII-transformed cells.Epidermal growth factor receptor targeting and challenges in glioblastoma.ReACT Phase II trial: a critical evaluation of the use of rindopepimut plus bevacizumab to treat EGFRvIII-positive recurrent glioblastoma.Therapeutic potential and challenges of natural killer cells in treatment of solid tumors An EGFRvIII targeted dual-modal gold nanoprobe for imaging-guided brain tumor surgery.Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies.Tetanus toxoid-loaded cationic non-aggregated nanostructured lipid particles triggered strong humoral and cellular immune responses.Effects of combined radiosurgery and temozolomide therapy on epidermal growth factor receptor and variant III in glioblastoma multiforme.

P2860

Q28083907-BDB3FC40-77E7-48C5-AD57-F962C28A1A14 Q36081073-F148ADF2-C729-4945-85FB-14A2637444E8 Q36977684-BB62C68A-B430-408F-A09E-0DBB36B07A0A Q38398440-46A0A5EF-BC25-46FE-AB6D-7DF03D101C4A Q38478878-6BC6634B-06CE-4C5D-AEA9-5334549A312E Q48552600-E6F29632-A4C4-446D-A1B5-5FEDFBCC07AD Q50100856-1626AD42-1C3A-4ACB-952A-177CFF8CA7F4 Q53127398-3EAAAE8E-C2BF-4329-AE41-B25B48BB9C56 Q55072630-3BB57CED-A43B-4FF4-8C89-29BCCEF28810

P2860

Epidermal growth factor receptor and variant III targeted immunotherapy.

http://www.wikidata.org/entity/Q34391942

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Epidermal growth factor receptor and variant III targeted immunotherapy.

@ast

Epidermal growth factor receptor and variant III targeted immunotherapy.

@en

Epidermal growth factor receptor and variant III targeted immunotherapy.

@nl

type

label

Epidermal growth factor receptor and variant III targeted immunotherapy.

@ast

Epidermal growth factor receptor and variant III targeted immunotherapy.

@en

Epidermal growth factor receptor and variant III targeted immunotherapy.

@nl

prefLabel

Epidermal growth factor receptor and variant III targeted immunotherapy.

@ast

Epidermal growth factor receptor and variant III targeted immunotherapy.

@en

Epidermal growth factor receptor and variant III targeted immunotherapy.

@nl

P1433

Q34391942-EAA45A4A-ABE0-42D9-AF12-C0F4DE68C925

P1476

Q34391942-0D7C5D30-2762-4020-B08E-32D8D87C5964

P2093

Q34391942-066AC495-284B-418A-944F-BE6D0F4C29D9

Q34391942-2C38FA60-DAFE-4F7A-978E-4D3D0C8388D2

Q34391942-50B685F0-7F14-4787-92D6-FED76B23A2B7

Q34391942-5D41085D-466E-4DE3-8DC7-D6634B7DE21B

Q34391942-B723DD80-9C20-4BB0-A434-AE3A6AE4E24E

P2860

Q34391942-04BEF943-C564-4C27-ABA7-A1741F0C1820

Q34391942-05068AC6-0DAB-4A30-801C-9680B2F22CEA

Q34391942-0855880A-F6E7-4334-A256-6A2397F19F5A

Q34391942-0EC3A57E-8D36-4207-8F6B-499ACBCC5447

Q34391942-18192976-C4A2-45B7-B213-16EBC0972E20

Q34391942-2949CA89-5AE0-424C-9AAB-64CB928C21F1

Q34391942-2F481FAC-65AA-4E9B-A148-B015984D3037

Q34391942-3A92FC8A-22F5-4CF4-84B9-E5702D5132B1

Q34391942-582116D3-5A3B-4811-9858-0FA7BE296A20

Q34391942-5A3A086A-FD12-4844-9BCA-BB10E12352DF

P304

Q34391942-5DF87B1C-EF3B-4A40-AF71-A506609FA081

P31

Q34391942-B03EE631-F1E2-4F2C-8565-CF8860A6C8CF

P356

Q34391942-445C9093-9D68-4895-97E8-29840F51E53C

P478

Q34391942-EBE5165F-B016-480B-8BC6-DE0F72C5EE5E

P50

Q34391942-4595C1BB-E107-432A-9963-9099EAE77225

Q34391942-7802D192-E76C-4D60-949C-948B696E7E29

P577

Q34391942-C91FA5EC-9CE9-477C-A52A-EA4F893449D4

P5875

Q34391942-8E9F6232-DCF3-487F-B950-66C42DA1968C

P698

Q34391942-ADB60092-15C5-4D57-9FFF-EB324AD6230C

P921

Q34391942-358262C7-C4C6-4751-946E-CC3EF6BC465D

P932

Q34391942-2FF8F9CB-7CB5-4A8A-82FF-042759A7E3F9

P356

P1433

P1476

Epidermal growth factor receptor and variant III targeted immunotherapy

@en

P2093

Amy B Heimberger

http://www.w3.org/2001/XMLSchema#string

Carter M Suryadevara

http://www.w3.org/2001/XMLSchema#string

Hillary G Caruso

http://www.w3.org/2001/XMLSchema#string

Kendra L Congdon

http://www.w3.org/2001/XMLSchema#string

Laurence J N Cooper

http://www.w3.org/2001/XMLSchema#string

P2860

EGFR phosphorylates tumor-derived EGFRvIII driving STAT3/5 and progression in glioblastoma

Tumor regression in cancer patients by very low doses of a T cell-engaging antibody

Cancer immunotherapy comes of age

Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2

Antigen spreading contributes to MAGE vaccination-induced regression of melanoma metastases.

Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma.

An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme

Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma.

Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma.

Antitumor efficacy of cytotoxic drugs and the monoclonal antibody 806 is enhanced by the EGF receptor inhibitor AG1478.

P304

viii20-5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NEUONC/NOU236

http://www.w3.org/2001/XMLSchema#string

P478

16 Suppl 8

http://www.w3.org/2001/XMLSchema#string

P50

Patrick C Gedeon

P577

2014-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

267738766

http://www.w3.org/2001/XMLSchema#string

P698

25342601

http://www.w3.org/2001/XMLSchema#string

P921

P932

4207138

http://www.w3.org/2001/XMLSchema#string